Stuart Poulton

EVP, Chief Development Officer

EVP, Chief Development Officer at Karyopharm Therapeutics Inc., filing insider transactions between 2026-02-17 and 2026-05-14.

Total Purchases

—

0 transactions

Total Sales

$55K

3 transactions

Companies Traded

3 total filings

Active Since

2026-02-17

Last: 2026-05-14

Companies

Karyopharm Therapeutics Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-05-14	KPTI	Sale	403	$9.50	$4K	94.8K	SEC ↗
2026-03-02	KPTI	Sale	5,101	$9.41	$48K	94.3K	SEC ↗
2026-02-17	KPTI	Sale	378	$8.63	$3K	99.4K